{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/07/3289923/0/en/ALX-Oncology-s-Evorpacept-in-Combination-with-Zanidatamab-Generates-Promising-Durable-Response-in-Patients-with-Advanced-HER2-Positive-Breast-Cancer-and-High-CD47-Expression.html", "message": "News view counter 709742 successfully enlarged"}